2025-12-11 Investor Supplementary Materials of Consolidated Financial Results for the Three Months Ended October 31 2025 2025-12-11 Investor [Summary]Consolidated Financial Results for the Three Months Ended October 31, 2025 (Under Japanese GAAP) 2025-11-17 Investor Notice Regarding the Disposal of Treasury Shares as Restricted Stock Compensation 2025-11-13 Research and Development Pharma Foods Partners with The University of Tokyo For Next-Generation Antibody Drug Discovery ～A Leap Forward with AI and Advanced Molecular Engineering～ 2025-09-30 Investor Notice of the 28th Annual General Meeting of Shareholders 2025-09-25 Investor Consolidated Financial Results for the Year Ended July 31, 2025 (Based on Japanese GAAP) 2025-09-24 Research and Development “ALAgene® technology”-Derived Antibody Therapeutic Candidate Achieves Phase I Clinical Milestone ～Driving Future Growth through Strategic License Agreement～ 2025-09-19 Investor Notice Regarding the Board of Directors’ Opinion on a Shareholder Proposal 2025-09-19 Investor Notice Regarding Partial Amendments to the Articles of Incorporation 2025-09-11 Investor [Summary] Consolidated Financial Results for the Fiscal Year Ended July 31, 2025 (Under Japanese GAAP) More